Plain-English translation of NCT06372015 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →This trial is comparing two approaches for people with severe obesity who also have liver disease: either following a structured dietary program with professional support, or undergoing weight loss surgery (such as gastric bypass or sleeve gastrectomy). Researchers will track changes in participants' blood markers, immune system, and special molecules called microRNAs to understand how each approach affects their health and whether surgery or diet works better for their particular situation.
Many people with severe obesity don't get relief from diet and exercise alone, and surgery can help—but doctors don't always know which patients will benefit most from surgery versus continuing with nutrition and lifestyle support. This study aims to understand the biological changes that happen with each approach, especially in people who have both obesity and liver disease, so doctors can make better treatment choices.
You likely qualify if…
You likely don't qualify if…
Depending on which group you're assigned to, you'll either work with a nutrition team on a structured eating plan, or you'll undergo weight loss surgery with support from doctors, a dietitian, psychologist, and physical therapist. Both groups will have blood tests and ultrasound imaging done to measure changes in liver health and special blood markers over time. The trial involves working with a multidisciplinary team to support your health improvements.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Italy